Net profit of Mankind Pharma rose 19.38% to Rs 501.03 crore in the quarter ended September 2023 as against Rs 419.71 crore during the previous quarter ended September 2022. Sales rose 11.64% to Rs 2708.10 crore in the quarter ended September 2023 as against Rs 2425.84 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales2708.102425.84 12 OPM %25.2124.35 - PBDT737.47611.60 21 PBT640.99533.01 20 NP501.03419.71 19 Powered by Capital Market - Live News

Mankind Pharma announced that Sikkim manufacturing facility has resumed its operations as usual with effect from 13 October 2023.Early October, the company`s operations at Daring Block, Berimok, Namchi Zilla, South Sikkim were disrupted due to disturbance in power/utility supply because of flash floods. Powered by Capital Market - Live News

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 31 October 2023.Powered by Capital Market - Live News

Mankind Pharma announced that the commercial operations with respect to pharmaceutical formulations has commenced at the Company`s newly set-up plant in Udaipur, Rajasthan with effect from 25 September 2023.Powered by Capital Market - Live News

Mankind Pharma announced that the 32th Annual General Meeting (AGM) of the company will be held on 22 September 2023.Powered by Capital Market - Live News